BUZZ-Valeant Pharmaceuticals International Inc: Hits record high

Thu Jul 23, 2015 10:16am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up about 4.2 pct at $249 after hitting record high of $252.79

** Toronto-listed stock rises 5.6 pct to hit record high of C$330

** Reports better-than-expected quarterly profit, helped by strength in its U.S. dermatology business

** Raises 2015 forecast to reflect sales of recently acquired Salix Pharmaceuticals' irritable bowel syndrome drug, Xifaxan

** Up to Wednesday's close, U.S-listed stock had risen about 21 pct since March 16, when Valeant trumped Endo International Plc for Salix